From votes to vision
23.05.19
As millions of Europeans exercise their right to vote in these European elections, we are excited about the potential of Europe’s research and healthcare community working together to fight disease. The pharmaceutical industry is committed to being part of that fight, discovering, developing and delivering new treatments and cures for patients across Europe.
As we await the results that will shape Europe’s new political landscape, we look forward to discussing a shared vision for a healthier Europe. To contribute to that dialogue, we have explored, in the EFPIA Manifesto, what we as the research-based industry can contribute to a healthier future for Europe and made 9 concrete proposals for consideration by policy makers across the EU. The Manifesto focuses on; bringing innovative health solutions to all patients, making the EU a world leader in research and development as well as being stronger together by joining forces to fast track results.
Speaking about the Manifesto, EFPIA’s Director General Nathalie MolI said. “I firmly believe that building a strong European economy and cohesive European society largely depends on a healthy population. This is why ensuring all European citizens live healthier lives must be a priority for the new legislative mandate, supported by more patient-centred health systems and a smart sectorial industrial policy in a truly pro-innovation environment.”
To help realise these goals, the EFPIA Manifesto contains proposals to:
- Drive the evolution towards outcomes-focused healthcare systems
- Improve patient access
- Build a coalition on vaccination
- Fast-track breakthrough therapies that address unmet needs
- Maintain and develop Europe’s world class intellectual property system
- Advance Europe’s Smart trade agenda
- Foster the adoption of new clinical trial design supported by digital tools
- Support a flexible legal framework for Public Private Partnerships in health
- Launch a new strategic dialogue on healthcare and life sciences in the EU
Nathalie Moll went on to say “The health of the EU’s citizens depends on all of us - policy-makers, healthcare professionals, civil society and industry. Pooling our resources and expertise will ensure that what we do brings tangible benefits to EU citizens and strengthens the EU’s global reputation for outstanding R&D and innovation. That is why we are pleased to share our vision for a healthier future for Europe and look forward to dialogue with all stakeholders as incoming MEPs take their seats and the new Commission is formed”.